Up-regulation of urinary markers predict outcome in igA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine

Clinical Nephrology

Volumn 80, Issue 3, 2013, Pages 203-210

  Stangou, Maria ^a   Papagianni, Aikaterini ^a   Bantis, Christos ^a   Moisiadis, Dimitrios ^a   Kasimatis, Stratis ^a   Spartalis, Michael ^a   Pantzaki, Afroditi ^b   Efstratiadis, George ^a   Memmos, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University Medical School   (Greece)

Author keywords

Creatment; IgA nephropathy; Oxford classification system; Prognosis; Urinary cytokines

Indexed keywords

AZATHIOPRINE; CREATININE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FISH OIL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HISTOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; AZATHIOPRINE; BIOLOGICAL MARKERS; BIOPSY; CREATININE; CYTOKINES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; STEROIDS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84884510025     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107836     Document Type: Article

References (24)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196. Cross- Ref PubMed
2. Philibert D, Cattran D, Cook T. Clinicopathologic correlation in IgA nephropathy. Semin Nephrol. 2008; 28: 10-17. CrossRef PubMed
3. Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L. Proteinuria in the prognosis of IgA nephropathy. Minerva Urol Nefrol. 2009; 61: 235-248. PubMed
4. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76: 534-545. CrossRef PubMed
5. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009; 76: 546-556. CrossRef PubMed
6. Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int. 1996; 50: 1990-2001. CrossRef PubMed
7. Torres DD, Rossini M, Manno C, Mattace-Raso F, D'Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int. 2008; 73: 327-333. Cross- Ref PubMed
8. Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton). 2009; 14: 613-620. CrossRef PubMed
9. Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria. Clin Exp Nephrol. 2003; 7: 210-214. CrossRef PubMed
10. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004; 15: 157-163. Cross- Ref PubMed
11. Reich HN, Troyanov S, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007; 18: 3177-3183. CrossRef PubMed
12. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a longterm follow up of 204 cases in China. Nephrology (Carlton). 2008; 13: 242-246. CrossRef PubMed
13. Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function. Am J Nephrol. 2011; 34: 233-240. CrossRef PubMed
14. Liu LJ, Li GT, Zhou Y, Lv JC, Zhang H. Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy. Nephron Clin Pract. 2010; 115: c161-c167. CrossRef PubMed
15. Niemir ZI, Ondracek M, Dworacki G, Stein H, Waldherr R, Ritz E, Otto HF. In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis. 1998; 32: 80-92. CrossRef PubMed
16. Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lu pus nephritis. Lupus. 2012; 21: 1385-1396. CrossRef PubMed
17. Niemir ZI, Stein H, Dworacki G, Mundel P, Koehl N, Koch B, Autschbach F, Andrassy K, Ritz E, Waldherr R, Otto HF. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int. 1997; 52: 393-403. CrossRef PubMed
18. Myllymäki JM, Honkanen TT, Syrjänen JT, Helin HJ, Rantala IS, Pasternack AI, Mustonen JT. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int. 2007; 71: 343-348. CrossRef PubMed
19. Panzer U, Kurts C. T cell cross-talk with kidney dendritic cells in glomerulonephritis. J Mol Med (Berl). 2010; 88: 19-26. CrossRef PubMed
20. Wada T, Furuichi K, Segawa-Takaeda C, Shimizu M, Sakai N, Takeda SI, Takasawa K, Kida H, Kobayashi KI, Mukaida N, Ohmoto Y, Matsushima K, Yokoyama H. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int. 1999; 56: 995-1003. CrossRef PubMed
21. Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy. Clin Nephrol. 2011; 76: 144-150. PubMed
22. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2005; 16: 467-473. CrossRef PubMed
23. Pathak S, Goldofsky E, Vivas EX, Bonagura VR, Vambutas A. IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol. 2011; 186: 1870-1879. CrossRef PubMed
24. Butts CL, Shukair SA, Duncan KM, Bowers E, Horn C, Belyavskaya E, Tonelli L, Sternberg EM. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol. 2007; 19: 287-296. CrossRef PubMed